Deleted Tweets From Scott Gottlieb, R-D.C.

THREAD: 1/2 In a forthcoming #FDA study, which we’ll be releasing shortly, we found that for a large set of high-volume generic drugs, manufacturers’ prices in the U.S. in 2017 were significantly less than the foreign prices charged in eight of nine foreign countries we studied https://t.co/YpCXdKER9p

#FDA has launched a broad campaign to educate the nation's youth about the dangers of e-cigarettes and nicotine as we combat a sharp rise in the use of these products by high school and middle school aged children: https://t.co/apMMpN748L

RT @SGottliebFDA: THREAD: 1/2 In a forthcoming #FDA study, which we’ll be releasing shortly, we found that for a large set of high-vo… https://t.co/caVOeOwWMF

We’ll be taking additional actions to address a sharp spike we’ve seen in youth use of e-cigs across both high school and middle school kids. We’ve begun outreach to manufacturers and welcome their own steps. But #FDA will act decisively where we must https://t.co/KjYZO1XecF

Last week #FDA launched “The Real Cost” E-cigarette Prevention Campaign designed to snap teens out of their “cost-free” mentality by educating them about the potential risks of these products, urging them to “know the real cost of vaping.” https://t.co/MAb8XNaugK https://t.co/BZxGuKOB3Q

RT @DrugChannels: Kudos to @US_FDA and @SGottliebFDA ! There were 719 approved #generic #drug ANDAs for the first 11 months of gov't… https://t.co/RPBiwW08cf

RT @FDA_MCMi: FDA scientists are developing tools to help ensure that MCMs to combat emerging infectious diseases, and chemical,… https://t.co/sEO8OgQIPq

RT @RAPSorg: Drug Competition Action Plan: @US_FDA Issues One Draft, One Final Guidance | #Regulatory Focus… https://t.co/cNU0G0YCzS

RT @FDASpox: We are pleased to support research for a variety of rare diseases that have little, or no, treatment options. Today… https://t.co/BSkRRNugRM

RT @FDATobacco: REMINDER: FDA will hold a public meeting about the tobacco product review process. � Oct. 22-23, 2018 � Rockville,… https://t.co/JBJNbBgALL

RT @califf001: Amen! @DukeForge https://t.co/K8TPUo4uVL QT @SGottliebFDA: #FDA’s Dr. Janet Woodcock - one of the most significant and thoughtfully independent minded public health official… https://t.co/D3L4hsDRmV)

#FDA’s Dr. Janet Woodcock - one of the most significant and thoughtfully independent minded public health officials of our time - brings her dedication to patients and her fidelity to innovation, patient safety, and the advancement of medical science to the board of PCORI. QT @USGAO: Press Release: GAO Makes Appointments to the Patient-Centered Outcomes Research Institute (PCORI) Governing Board:… https://t.co/U3aYIPxDnT)

RT @US_FDA: Statement from FDA Commissioner @SGottliebFDA on new FDA commitment to disclose retailer information for certain fo… https://t.co/8GpcaoebV1

RT @MedTech_Danny: .@US_FDA's Jeff Shuren: CDRH expecting to issue least burdensome final guidance by year's end. #MedTechCon

I’ll be getting my vaccine tomorrow @DrNancyM_CDC. Picture (and band-aid) to come #FightFlu #VaccinesWork QT @DrNancyM_CDC: Have you gotten a #fluvaccine? I got mine. This week I’ll share images of my peers getting vaccinated and I encoura… https://t.co/DUm62lrL6u)

RT @US_FDA: In the inaugural #FDAVoices, Commissioner @SGottliebFDA talks about advancing innovation in digital health. You can… https://t.co/pL9tt4oiCf

RT @SecAzar: Infectious threats do not respect boundaries between countries and can rapidly spread. We're committed to working i… https://t.co/8OZuKdPiIo

RT @FDASpox: Today we launched #FDAVoices with a perspective from our Commissioner @SGottliebFDA on advancing innovation in digi… https://t.co/sdNiSXkYyP

RT @CNN: A new FDA campaign will highlight the dangers of e-cigarettes to young people. For the first time, the agency will… https://t.co/N8l9TUpY1D

RT @US_FDA: Today, #FDA unveiled #FDAVoices, a new and improved resource that highlights thought-provoking insights and perspec… https://t.co/3B4w7BAYIP

THREAD: 1/2 In a forthcoming #FDA study, which we’ll be releasing shortly, we found that for a large set of high-volume generic drugs, manufacturers’ prices in the U.S. in 2017 were significantly less than the foreign prices charged in eight of nine foreign countries we studied https://t.co/YpCXdKER9p

#FDA has launched a broad campaign to educate the nation's youth about the dangers of e-cigarettes and nicotine as we combat a sharp rise in the use of these products by high school and middle school aged children: https://t.co/apMMpN748L

RT @SGottliebFDA: THREAD: 1/2 In a forthcoming #FDA study, which we’ll be releasing shortly, we found that for a large set of high-vo… https://t.co/caVOeOwWMF

We’ll be taking additional actions to address a sharp spike we’ve seen in youth use of e-cigs across both high school and middle school kids. We’ve begun outreach to manufacturers and welcome their own steps. But #FDA will act decisively where we must https://t.co/KjYZO1XecF

Last week #FDA launched “The Real Cost” E-cigarette Prevention Campaign designed to snap teens out of their “cost-free” mentality by educating them about the potential risks of these products, urging them to “know the real cost of vaping.” https://t.co/MAb8XNaugK https://t.co/BZxGuKOB3Q

RT @DrugChannels: Kudos to @US_FDA and @SGottliebFDA ! There were 719 approved #generic #drug ANDAs for the first 11 months of gov't… https://t.co/RPBiwW08cf

RT @FDA_MCMi: FDA scientists are developing tools to help ensure that MCMs to combat emerging infectious diseases, and chemical,… https://t.co/sEO8OgQIPq

RT @RAPSorg: Drug Competition Action Plan: @US_FDA Issues One Draft, One Final Guidance | #Regulatory Focus… https://t.co/cNU0G0YCzS

RT @FDASpox: We are pleased to support research for a variety of rare diseases that have little, or no, treatment options. Today… https://t.co/BSkRRNugRM

RT @FDATobacco: REMINDER: FDA will hold a public meeting about the tobacco product review process. � Oct. 22-23, 2018 � Rockville,… https://t.co/JBJNbBgALL

RT @califf001: Amen! @DukeForge https://t.co/K8TPUo4uVL QT @SGottliebFDA: #FDA’s Dr. Janet Woodcock - one of the most significant and thoughtfully independent minded public health official… https://t.co/D3L4hsDRmV)

#FDA’s Dr. Janet Woodcock - one of the most significant and thoughtfully independent minded public health officials of our time - brings her dedication to patients and her fidelity to innovation, patient safety, and the advancement of medical science to the board of PCORI. QT @USGAO: Press Release: GAO Makes Appointments to the Patient-Centered Outcomes Research Institute (PCORI) Governing Board:… https://t.co/U3aYIPxDnT)

RT @US_FDA: Statement from FDA Commissioner @SGottliebFDA on new FDA commitment to disclose retailer information for certain fo… https://t.co/8GpcaoebV1

RT @MedTech_Danny: .@US_FDA's Jeff Shuren: CDRH expecting to issue least burdensome final guidance by year's end. #MedTechCon

I’ll be getting my vaccine tomorrow @DrNancyM_CDC. Picture (and band-aid) to come #FightFlu #VaccinesWork QT @DrNancyM_CDC: Have you gotten a #fluvaccine? I got mine. This week I’ll share images of my peers getting vaccinated and I encoura… https://t.co/DUm62lrL6u)

RT @US_FDA: In the inaugural #FDAVoices, Commissioner @SGottliebFDA talks about advancing innovation in digital health. You can… https://t.co/pL9tt4oiCf

RT @SecAzar: Infectious threats do not respect boundaries between countries and can rapidly spread. We're committed to working i… https://t.co/8OZuKdPiIo

RT @FDASpox: Today we launched #FDAVoices with a perspective from our Commissioner @SGottliebFDA on advancing innovation in digi… https://t.co/sdNiSXkYyP

RT @CNN: A new FDA campaign will highlight the dangers of e-cigarettes to young people. For the first time, the agency will… https://t.co/N8l9TUpY1D

RT @US_FDA: Today, #FDA unveiled #FDAVoices, a new and improved resource that highlights thought-provoking insights and perspec… https://t.co/3B4w7BAYIP